GSK to cut 850 more research jobs
Wednesday 01 October 2008
The UK's biggest drug maker, GlaxoSmithKline, said yesterday that it is axing as many as 850 jobs in its British and US research and development units. The cuts, intended to improve productivity, are in addition to the 350 loses announced in June.
"Following a recent review of business operations, we have started consultation on proposals which could impact 850 roles in the UK and the US. It has been difficult to arrive at these proposals, but we believe these changes are necessary as part of GSK's longer-term strategy" a spokesperson said.
GSK is undertaking a review of its entire business, which was first announced at the end of 2007. The group hopes to save £700m by 2010, including £350m by the end of next year.
The spokesperson said that it is unclear at this stage how many jobs would be lost in the UK.
And why are 'southern' ways of speaking spreading north?
Ten best places to live in the UK: Solihull comes top
Paul Walker autopsy: Results reveal Fast and Furious star's cause of death
Mysterious glowing ‘alien-like creature’ spotted in waters of Bristol Harbour. A jellyfish - or something fishy?
From 'terrorist' to tea with the Queen
Nelson Mandela death: his life in pictures
- 1 Cameron's freebie to apartheid South Africa
- 2 Nelson Mandela life story: An unconquerable spirit
- 3 Is this the scariest advert ever? Japanese tyre commercial comes with its own disclaimer and health warning
- 4 A forgotten episode in Russian history leaves links with the Philippines
- 5 Video: Students 'punched and dragged to the ground by their hair' as police break up demonstration
iJobs Money & Business
£50000 - £65000 per annum + benefits + bonus: Harrington Starr: Market Data SM...
£50000 - £70000 per annum + benefits + bonus: Harrington Starr: Business Analy...
£70000 - £85000 per annum + benefits + bonus: Harrington Starr: Business Analy...
£75000 - £85000 per annum + Bonus and Benefits: Harrington Starr: An award win...